Bill > SB0150

This bill, effective July 1, 2026, amends Indiana law to cap the out-of-pocket cost for individuals with health insurance for a 30-day supply of prescription insulin drugs at $35, regardless of how many prescriptions or different types of insulin are filled during that period. A "prescription insulin drug" is defined as a drug containing insulin, used to treat diabetes, and prescribed as medically necessary. The bill also allows insurers to set the cap lower than $35 and includes an exception: if applying this $35 cap would prevent a health insurance plan from qualifying as a high deductible health plan under Section 223 of the Internal Revenue Code, the cap will not apply to the extent necessary to maintain that qualification.

Health and Social Services

https://iga.in.gov/legislative/2026/bills/senate/150/details